Florida Institute for Reproductive Medicine

What Florida Institute for Reproductive Medicine does

Florida Institute for Reproductive Medicine (FIRM) is a privately held, for-profit fertility practice headquartered in Jacksonville, Florida, founded circa 1991. The practice operates five clinical locations across North Florida and South Georgia (Jacksonville downtown, Jacksonville South, Daytona Beach, Tallahassee, and Valdosta, GA) and provides a comprehensive suite of reproductive medicine services including in vitro fertilization (IVF) in multiple program variants (single cycle, cryopreserved, minimal stimulation, three-cycle, banking, and shared-risk guarantee), intrauterine insemination (IUI), ovulation induction, gonadotropin therapy, donor egg/sperm/embryo programs, gestational surrogacy coordination, egg/sperm/embryo cryopreservation, preimplantation genetic testing (PGS/PGD, including in-house NGS), and advanced laparoscopic/robotic surgery. Underlying technical capabilities include embryology and andrology labs at the flagship, day-5 embryo biopsy, vitrification, ICSI, and an in-house pharmacy, supporting 20,000+ reported births over 35+ years of operation.

FIRM is led by four board-certified reproductive endocrinologists — founder Dr. Kevin Winslow, Dr. Teresa Erb, Dr. Adrienne Gentry, and Dr. Viji Sundaram — supported by doctoral-level embryologists and a nursing team averaging 15 years of reproductive medicine experience. The practice's revenue model is direct-to-consumer and transaction-based, with per-cycle fees that are advertised at 10-20% below national averages, tiered outcome-based "guarantee" programs with partial or full refunds, financing via LendingClub Patient Solutions, and acceptance of most major insurance plans including TriCare. Multi-channel patient acquisition is led by a content-rich website with transparent pricing and bilingual (English/Spanish) education, active social media (Facebook, Instagram, X), earned media coverage, and partnerships with Igenomix (genetic testing), Fairfax EggBank (donor eggs), and North Florida Gynecology Specialists (robotic surgery). The practice has been consecutively recognized by Newsweek/Statista among America's Best Fertility Clinics in 2023 and 2025.

Operationally, FIRM is independent — there is no disclosed parent company, venture, or private equity ownership. Recent capital deployment has been organic: the opening of a new state-of-the-art IVF center in the One Call Tower in late 2023/2024 and ongoing hiring across clinical and administrative functions. The geographic footprint covers non-mandate states (FL/GA) for infertility coverage, positioning cost efficiency and outcome-based pricing as the primary demand drivers.

Name

Florida Institute for Reproductive Medicine

Legal name

Florida Institute for Reproductive Medicine

Website

https://fertilityjacksonville.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Florida Institute for Reproductive Medicine (FIRM) is a private Jacksonville, Florida-based fertility practice operating five clinics across North Florida and South Georgia, offering IVF, IUI, donor programs, fertility preservation, and advanced reproductive surgery to individuals and couples seeking to build families.

Ownership category

akta.pro rank

Product category

Reproductive Medicine and Fertility Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Reproductive Endocrinology & Infertility (Endocrine) (HLAKADAI)

Keywords

• Fertility treatment services
• In vitro fertilization
• Reproductive endocrinology
• Fertility preservation
• Assisted reproduction

Headquarters

HQ city

Jacksonville

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Fertility treatment services: Direct revenue from IVF cycles, IUI procedures, ovulation induction, gonadotropin therapy, and surgical procedures. Fees include cycle monitoring, retrievals, transfers, embryology services, and cryopreservation. Multiple pricing tiers based on treatment complexity and program type.
2. Donor programs: Revenue from donor egg, donor sperm, and donor embryo programs including cryopreserved donor oocyte IVF and known donor egg cycles
3. Insurance billing: Accepts most major insurance plans including TriCare. Florida and Georgia do not mandate infertility coverage, so insurance coverage varies by patient
4. Fertility preservation: Egg freezing, sperm freezing, and embryo cryopreservation services with storage fees
5. Financing programs: Financing provided through LendingClub Patient Solutions for fertility treatment financing

Pricing tiers

Go-to-market motion1 record

Distribution channels8 records

Marketing channels10 records

Core offering

Florida Institute for Reproductive Medicine is a private fertility clinic providing a full spectrum of assisted reproductive technology services, including in vitro fertilization (IVF) with multiple program variants, intrauterine insemination (IUI), ovulation induction, donor egg/sperm/embryo programs, fertility preservation (egg, sperm and embryo cryopreservation), preimplantation genetic testing, gestational surrogacy coordination, and minimally invasive reproductive surgery. The practice operates five clinic locations across North Florida and South Georgia with in-house embryology, andrology, endocrine labs and an on-site pharmacy, serving individual patients and couples seeking fertility care.

Product overview

Florida Institute for Reproductive Medicine (F.I.R.M.) operates as a comprehensive fertility care platform offering a full spectrum of reproductive medicine services across five locations in North Florida and South Georgia. The core offerings center around In Vitro Fertilization (IVF) with multiple program variants including Single IVF Cycle, Cryopreserved IVF, Minimal Stimulation (MINI STIM), Three Cycle IVF Program, IVF Guarantee Program, Three Cycle IVF Banking Plan, and Clomid Banking Program. The organization provides complete reproductive care including ovulation induction, intrauterine inseminations (IUI), andrology services, donor programs (donor eggs, donor embryos, gestational surrogacy), fertility preservation (egg/sperm/embryo cryopreservation), pre-implantation genetic testing (PGS/PGD), gender selection, and advanced laparoscopic/robotic surgery. Additional services include psychological consultation, genetics counseling, and an in-house pharmacy. The practice is recognized among the top fertility programs nationally, with over 20,000 babies born and 35 years of operation.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) Comprehensive IVF service including ovarian stimulation, egg retrieval, fertilization, embryo transfer, and cryopreservation of remaining embryos, with advanced laboratory techniques, genetic testing options, and personalized protocols. Sold to individual patients and couples facing infertility.
• Single IVF Cycle Standard fresh IVF cycle using fertility medications for ovarian stimulation, followed by egg retrieval, fertilization, embryo transfer, and freezing of additional embryos. Base cost $7,290 plus medications $3,000-$7,000. Sold to individual patients and couples.
• Cryopreserved IVF Cycle Thaw and transfer of previously cryopreserved embryos in an estrogen/progesterone-prepared cycle. Cost range $4,481-$5,774 plus medications. Sold to patients with stored embryos.
• Minimal Stimulation IVF (Mini Stim) Lower-intensity drug regimen IVF producing fewer eggs, with lower drug and monitoring costs, suitable for women not wanting embryo freezing or those with poor ovarian reserve. Cost $5,754 plus medications. Sold to individual patients seeking lower-cost or low-response protocols.
• Three Cycle IVF Program Up to three fresh IVF cycles with all micromanipulation services (ICSI, assisted hatching) and frozen embryo transfers included within 18 months. Heavily discounted at $20,270 plus medications. Sold to patients who need multiple IVF attempts.
• IVF Guarantee Program (Shared Risk) Up to three fresh IVF cycles with frozen embryo transfers, with 70% refund if pregnancy to 20 weeks does not occur after completing all cycles and transfers. Cost $24,720 with strict eligibility criteria. Sold to eligible patients seeking outcome-based pricing.
• Three Cycle IVF Banking Plan Three fresh IVF cycles with blastocyst cryopreservation and in-house PGS/NGS testing (up to 16 embryos) plus one frozen embryo transfer, designed for women of advanced reproductive age. Cost $39,670. Sold to women of advanced maternal age.
• Clomid Banking IVF Program Three Clomid IVF cycles with blastocyst cryopreservation, intended for very low response patients who would not get more than 1-3 eggs with high-dose gonadotropin therapy. Cost $20,220 plus medications. Sold to low ovarian reserve patients.
• Intrauterine Insemination (IUI) Artificial insemination placing washed sperm directly into the uterus via catheter, often combined with ovulation medication. Baseline ultrasound $320, insemination $600. Sold to patients seeking less invasive first-line fertility treatment.
• Andrology Services Male infertility testing and treatment including semen analysis (Kruger criteria), anti-sperm antibody testing, semen washes for artificial insemination, and semen cryopreservation. Sold to male patients and couples with male factor infertility.
• Ovulation Induction Oral medications (Clomiphene/Letrozole) to induce ovulation by stimulating brain signals for increased ovary-stimulating hormones. Sold to patients with ovulatory disorders.
• Gonadotropin Superovulation Injectable hormone therapy (Bravelle, Follistim, Gonal-f, Menopur, Repronex) for more powerful egg development stimulation than oral medications. Sold to patients requiring stronger stimulation protocols.
• Cryopreserved Donor Oocyte IVF Donor egg IVF using vitrified donor eggs from an egg bank for scheduling flexibility. Cost $12,281-$13,143 plus medications. Sold to patients needing donor eggs.
• Known Donor Egg IVF Non-split donor egg cycle with a known donor undergoing stimulation while the recipient uses hormone replacement for synchronized lining development. Cost $24,397-$25,259. Sold to recipients using a known donor.
• Donor Egg IVF Guarantee Program Up to three donor egg IVF cycles plus cryopreserved transfers, with full refund if pregnancy to 20 weeks is not achieved. Cost $35,850. Recipient must be 47 or younger with strict eligibility. Sold to patients seeking outcome-based donor egg pricing.
• Egg (Oocyte) Cryopreservation Female fertility preservation using vitrification. Egg retrieval cost $8,250 plus medications $3,000-$7,000. Future use cycle $6,281-$8,743. Sold to women seeking fertility preservation (medical or elective).
• Semen Cryopreservation Male fertility preservation through sperm freezing and storage for future use. Sold to men facing fertility-affecting treatments or seeking reproductive preservation.
• Embryo Cryopreservation Cryopreservation of excess embryos from IVF cycles with one year of storage included. Sold to IVF patients with surplus embryos.
• Gestational Surrogacy Medical and surgical evaluation and coordination for intended parents and surrogates. Florida requires legal marriage for gestational surrogacy. Process takes 6-9 months. Sold to intended parents needing a gestational carrier.
• Pre-embryo Genetic Screening/Diagnosis (PGS/PGD) with Gender Selection Day-five embryo biopsy with chromosomal screening to identify chromosomally normal embryos; supports gender selection for medical indications (sex-linked diseases) or family balancing at approximately 95% accuracy. Improves IVF pregnancy rates and decreases miscarriage rates. Sold to IVF patients seeking genetic screening.
• Genetics Consultation Genetic counseling and testing coordination including family pedigree analysis and pre-embryo genetic testing (PGT) for inherited disorders. Sold to patients with family history of genetic disease.
• Advanced Laparoscopy Minimally invasive diagnostic and operative surgery for endometriosis, fibroids, ovarian cysts, adhesions, and tubal disease, performed outpatient under general anesthesia. Sold to patients requiring reproductive surgery.
• da Vinci Robotic Surgery Robotic-assisted laparoscopic surgery for complex myomectomies, endometriosis, and tubal reanastomosis, performed by affiliated North Florida Gynecology Specialists surgeons. Sold to patients requiring advanced reproductive surgery.
• Psychologic Consultation Emotional support and psychological consultation for patients facing infertility challenges, including stress management and coping strategies. Sold to patients seeking emotional support during treatment.
• In-House Pharmacy On-site pharmacy for added convenience and potential cost savings on fertility medications. Sold to FIRM patients to dispense treatment medications.

Quantifiable outcome

• Over 20,000 babies born through 35+ years of service
• +3 more outcomes

Named customers13 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• IgenomixcoreTechnology or IntegrationIgenomix provides pre-embryo genetic testing (PGT-A/PGS) services for FIRM's IVF patients. FIRM sends embryos to Igenomix for chromosomal screening. PGT-A testing costs $200 per embryo plus $415 shipping estimate. FIRM also coordinates with Igenomix for embryo biopsy services.
• Fairfax EggBankcoreChannel Partner/ Reseller/ DistributorFIRM refers patients to Fairfax EggBank for frozen donor eggs as an alternative to their own egg donor program. FIRM provides links to Fairfax EggBank on their website for patients seeking egg bank options.
• North Florida Gynecology Specialists, LLCcoreStrategic or Co-development PartnerDr. Mary Ellen Wechter and Dr. Paulami Guha, fellowship-trained minimally invasive gynecologic surgeons, provide robotic-assisted laparoscopic surgery services for FIRM patients including complex myomectomies, endometriosis surgeries, tubal reanastomosis, and myomectomy. Located in Jacksonville, FL.
• LendingClub Patient SolutionsminorGTM or Marketing PartnerLendingClub Patient Solutions provides financing options for FIRM patients to afford fertility treatments. FIRM markets this financing option to patients as a payment solution.
• TriCarecoreGTM or Marketing PartnerTriCare insurance is accepted at FIRM, providing coverage options for military families seeking fertility treatments. FIRM actively markets this acceptance.
• FollowMyHealth (Patient Portal)coreTechnology or IntegrationFollowMyHealth provides the patient portal platform used by FIRM for secure healthcare communications, appointment management, and accessing medical records.
• Resolve: The National Infertility AssociationminorGTM or Marketing PartnerDr. Viji Sundaram is an advocate through Resolve, participating in Washington D.C. advocacy efforts supporting legislation mandating coverage for infertility care. FIRM benefits from association with this advocacy organization.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Houston Fertility Institute: Regional multi-site fertility practice in Texas offering IVF, ICSI, PGT, donor, and fertility preservation. Comparable as a regionally dominant fertility provider with similar full-service clinical and lab capabilities.
• Seattle Reproductive Medicine: Multi-physician fertility practice in the Pacific Northwest offering IVF, IUI, donor programs, and LGBTQ family building. Comparable as a multi-specialty reproductive endocrinology practice with donor and surrogacy coordination.
• Prelude Fertility: Network of fertility clinics and partner practices across multiple US states offering IVF and reproductive services. Comparable as a multi-clinic reproductive medicine platform building footprint through acquisitions and de novo sites.
• ORM Fertility (Oregon Reproductive Medicine): Pacific Northwest fertility clinic with advanced embryology, PGT, donor, and surrogacy services. Comparable as a full-service, outcomes-focused fertility practice with in-house lab capabilities.
• Shady Grove Fertility: Large multi-site US fertility practice offering IVF, donor, and shared-risk/refund programs. Directly comparable to FIRM in service mix, especially FIRM's IVF Guarantee and Donor Egg Guarantee programs.
• Reproductive Medicine Associates (RMA): Large national fertility network operating multiple clinic sites offering IVF, IUI, donor, and fertility preservation services. Directly comparable as a multi-location reproductive endocrinology and infertility platform serving similar patient segments.
• Boston IVF: Multi-location fertility practice offering a comprehensive suite of IVF, donor, and reproductive endocrinology services. Comparable in clinical scope and program-level pricing structures (e.g., multi-cycle and guarantee plans).
• CCRM Fertility: Network of fertility clinics providing IVF, PGT, donor egg, and fertility preservation. Comparable as a geographically distributed fertility practice competing for similar self-pay and insured patients on clinical outcomes and brand.

Broad incumbents

• Inception Fertility: Parent company platform of fertility clinics and adjacent services (including The Prelude Network). Broader incumbent comparable as a consolidator that competes for the same patient demand and physician talent pool.
• US Fertility: Operating company partnership of fertility practices including Shady Grove Fertility. Comparable as a large platform competing for the same patient demographic and acquiring independent clinics like FIRM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/firmjax
• Facebookfacebook.com/firmjax
• Instagraminstagram.com/firmjax
• LinkedInlinkedin.com/company/florida-institute-for-reproductive-medicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Florida Institute for Reproductive Medicine